Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review

Date: December 20, 2016
Pages: 61
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: G8C59F02242EN
Leaflet:

Download PDF Leaflet

Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review
Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Gilead Sciences Inc (Gilead) is a research-based biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative medicines for diseases with unmet medical need. The company offers products in various therapeutic areas including cardiovascular, respiratory, inflammation, liver diseases, cancer and HIV/AIDS. Gilead operates through more than 40 marketing subsidiaries in the in Europe, North America, South America, Asia-Pacific, the Middle East, Africa and Australia. The company enters into partnerships with organizations in science, academia and business to develop innovative medicines. It continues to add to its existing portfolio of products through internal discovery and clinical development programs; and through a product acquisition and in-licensing strategy. Gilead is headquartered in Foster City, California, the US.

Gilead Sciences Inc Key Recent Developments

Dec 16, 2016: Merck's subsidiary wins $2.5bn patent verdict against Gilead Sciences
Nov 16, 2016: Gilead Sciences Announces Promotion of James R. Meyers to Executive Vice President, Worldwide Commercial Operations
Nov 01, 2016: Gilead Sciences Announces Third Quarter 2016 Financial Results
Oct 24, 2016: Gilead Sciences announces encouraging data from two Phase III HIV-1 studies
Oct 18, 2016: The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers. - The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

    Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

    Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

    Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

    Note: Some sections may be missing if data is unavailable for the company
  • SECTION 1 - ABOUT THE COMPANY

    Gilead Sciences Inc - Key Facts
    Gilead Sciences Inc - Key Employees
    Gilead Sciences Inc - Key Employee Biographies
    Gilead Sciences Inc - Major Products and Services
    Gilead Sciences Inc - Pharmaceutical Pipeline Products Data
    Gilead Sciences Inc, Pipeline Products by Therapy Area
    Gilead Sciences Inc, Pipeline Products by Development Phase
    Gilead Sciences Inc - History
    Gilead Sciences Inc - Locations And Subsidiaries
    Head Office
    Other Locations & Subsidiaries
    Joint Venture

    SECTION 2 – COMPANY ANALYSIS

    Gilead Sciences Inc - Business Description
    Gilead Sciences Inc - Corporate Strategy
    Gilead Sciences Inc - SWOT Analysis
    SWOT Analysis - Overview
    Gilead Sciences Inc - Strengths
    Gilead Sciences Inc - Weaknesses
    Gilead Sciences Inc - Opportunities
    Gilead Sciences Inc - Threats
    Gilead Sciences Inc - Key Competitors

    SECTION 3 – COMPANY FINANCIAL RATIOS

    Financial Ratios - Capital Market Ratios
    Financial Ratios - Annual Ratios
    Performance Chart
    Financial Performance
    Financial Ratios - Interim Ratios
    Financial Ratios - Ratio Charts

    SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

    Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Gilead Sciences Inc, Recent Deals Summary

    SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

    Dec 16, 2016: Merck's subsidiary wins $2.5bn patent verdict against Gilead Sciences
    Dec 16, 2016: Merck's subsidiary wins $2.5bn patent verdict against Gilead Sciences
    Nov 16, 2016: Gilead Sciences Announces Promotion of James R. Meyers to Executive Vice President, Worldwide Commercial Operations
    Nov 01, 2016: Gilead Sciences Announces Third Quarter 2016 Financial Results
    Oct 24, 2016: Gilead Sciences announces encouraging data from two Phase III HIV-1 studies
    Oct 18, 2016: The Leukemia & Lymphoma Society Launches Groundbreaking Precision Medicine Approach to Treat Acute Myeloid Leukemia, One of the Deadliest Blood Cancers
    Aug 23, 2016: Kelly A. Kramer Joins Gilead Sciences’ Board of Directors
    Aug 11, 2016: ATF Urges Treasury and IRS to Act Against Gilead Science’s Massive Offshore Tax Dodging
    Aug 04, 2016: Tata Trusts and Gilead sign memorandum of understanding to address viral hepatitis in India
    Jul 25, 2016: Gilead Sciences Announces Second Quarter 2016 Financial Results

    SECTION 6 – APPENDIX

    Methodology
    Ratio Definitions
    About GlobalData
    Contact Us
    Disclaimer

    LIST OF TABLES

    Gilead Sciences Inc, Key Facts
    Gilead Sciences Inc, Key Employees
    Gilead Sciences Inc, Key Employee Biographies
    Gilead Sciences Inc, Major Products and Services
    Gilead Sciences Inc, Number of Pipeline Products by Therapy Area
    Gilead Sciences Inc, Number of Pipeline Products by Development Stage
    Gilead Sciences Inc, History
    Gilead Sciences Inc, Other Locations
    Gilead Sciences Inc, Subsidiaries
    Gilead Sciences Inc, Joint Venture
    Gilead Sciences Inc, Key Competitors
    Gilead Sciences Inc, Ratios based on current share price
    Gilead Sciences Inc, Annual Ratios
    Gilead Sciences Inc (Cont...1), Annual Ratios
    Gilead Sciences Inc, Interim Ratios
    Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
    Gilead Sciences Inc, Recent Deals Summary
    Currency Codes
    Capital Market Ratios
    Equity Ratios
    Profitability Ratios
    Cost Ratios
    Liquidity Ratios
    Leverage Ratios
    Efficiency Ratios

    LIST OF FIGURES

    Gilead Sciences Inc, Pipeline Products by Therapy Area
    Gilead Sciences Inc, Pipeline Products by Development Phase
    Gilead Sciences Inc, Performance Chart (2011 - 2015)
    Gilead Sciences Inc, Ratio Charts
    Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
    Gilead Sciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016
    Skip to top


    Ask Your Question

    Gilead Sciences Inc (GILD) - Financial and Strategic SWOT Analysis Review
    Company name*:
    Contact person*:
    Phone/fax*:
    Email*:
    Request invoice
    Your enquiry:
    Please click on a Check Box below to confirm you are not a robot: